Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Today's pharmaceutical stocks are facing ... 150 percent to US$5.34 on February 6, following the company’s February 4 release of positive top-line results from its Phase 2 FIGHT DMD trial.

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Eli Lilly and Company, Corcept Therapeutics, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks represent the publicly ...

However, J&J’s biggest moneymaker is its pharmaceutical segment. The company’s top-selling pharmaceutical products include autoimmune disease drug Stelara, blood cancer drugs Darzalex and ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in the US, as per some estimates.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

The US president vows "major" tariffs on imported medicines - raising fears of an increase in costs for Americans.